In liver cirrhosis, the normal functioning of hemostasis is disrupted, which leads to an increased risk of both thrombosis and bleeding. The study of platelet changes in such patients helps to understand the pathogenesis of these disorders and contributes to improved diagnostics and therapy.

chronic hepatitis, liver cirrhosis, platelet, blood test.

De Lédinghen, V., et al. Clinical impact of thrombocytopenia in liver disease: pathophysiology and management. /World Journal of Gastroenterology.- 2016.

Franco E., Bagnato B., Marino M. G., Meleleo C., Serino L., Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):74.

Moore AH. Thrombocytopenia in Cirrhosis?: A Review of Pathophysiology and Management Options. Am Assoc Study Liver Dis. 2019;14(5):183–6.

Osada M, Kaneko M, Sakamoto M, Endoh M, Takigawa K, Suzuki-inoue K, et al. Causes of Thrombocytopenia in Chronic Hepatitis C Viral Infection. SAGE Journals [Internet]. 2012;18(3):272–80. Available from: https://doi.org/10.1177/1076029611429124

Shao L, Zhang S, Wang N, Yu W, Chen M, Xiao N, et al. Platelet indices significantly correlate with liver fibrosis in HCV-infected patients. PLoS One [Internet]. 2020;1–9. Available from: http://dx.doi.org/10.1371/journal.pone.0227544

Shiffman, M. L., et al. "Thrombocytopenia in patients with chronic liver disease." /Journal of Clinical Gastroenterology.- Volume 48.- Issue 6.- June 2008.-Pages 1000-1007